122 related articles for article (PubMed ID: 7149928)
1. C1 inactivator and C3b inactivator in peripheral lymph of normal men.
Olszewski WL; Lukomska B; Engeset A
Arch Immunol Ther Exp (Warsz); 1982; 30(1-2):79-86. PubMed ID: 7149928
[TBL] [Abstract][Full Text] [Related]
2. Haemolytic complement in peripheral lymph of normal men.
Olszewski WL; Engeset A
Clin Exp Immunol; 1978 Jun; 32(3):392-8. PubMed ID: 99278
[TBL] [Abstract][Full Text] [Related]
3. Capillary transport of immunoglobulins and complement proteins to the interstitial fluid and lymph.
Olszewski WL; Engeset A
Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):57-65. PubMed ID: 749810
[TBL] [Abstract][Full Text] [Related]
4. Evidence for glomerular modulation of complement activation.
Moseley HL; Whaley K
J Clin Lab Immunol; 1979 Apr; 2(1):9-13. PubMed ID: 95813
[TBL] [Abstract][Full Text] [Related]
5. Complement inhibitors in normal cornea and aqueous humor.
Mondino BJ; Sumner H
Invest Ophthalmol Vis Sci; 1984 Apr; 25(4):483-6. PubMed ID: 6706511
[TBL] [Abstract][Full Text] [Related]
6. Complement levels in cigarette smokers: elevation of serum concentrations of C5, C9, and C1-inhibitor.
Wyatt RJ; Bridges RB; Halatek DG
J Clin Lab Immunol; 1981 Sep; 6(2):131-5. PubMed ID: 7288869
[TBL] [Abstract][Full Text] [Related]
7. Restoration by purified C3b inactivator of complement-mediated function in vivo in a patient with C3b inactivator deficiency.
Ziegler JB; Alper CA; Rosen RS; Lachmann PJ; Sherington L
J Clin Invest; 1975 Mar; 55(3):668-72. PubMed ID: 1117072
[TBL] [Abstract][Full Text] [Related]
8. C1 subcomponent complexes: basic and clinical aspects.
Laurell AB; Sjöholm AG
Behring Inst Mitt; 1993 Dec; (93):292-8. PubMed ID: 8172579
[TBL] [Abstract][Full Text] [Related]
9. Inactivator of the first component of human complement (C1INA). Enhancement of C1INA activity against C1s by acidic mucopolysaccharides.
Nagaki K; Inai S
Int Arch Allergy Appl Immunol; 1976; 50(2):172-80. PubMed ID: 128530
[TBL] [Abstract][Full Text] [Related]
10. Control of complement activation in membranous and membranoproliferative glomerulonephritis.
Moseley HL; Whaley K
Kidney Int; 1980 Apr; 17(4):535-44. PubMed ID: 6446614
[TBL] [Abstract][Full Text] [Related]
11. C3b inactivator in normal mice and mice infected with Plasmodium berghei berghei.
Okerengwo AA
Afr J Med Med Sci; 1988 Sep; 17(3):171-4. PubMed ID: 2845758
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of the hemolytic activity of the first component of complement C1 by an Escherichia coli C1q binding protein.
van den Berg RH; Faber-Krol MC; van de Klundert JA; van Es LA; Daha MR
J Immunol; 1996 Jun; 156(11):4466-73. PubMed ID: 8666822
[TBL] [Abstract][Full Text] [Related]
13. Complement activation in chronic liver disease.
Munoz LE; De Villiers D; Markham D; Whaley K; Thomas HC
Clin Exp Immunol; 1982 Mar; 47(3):548-54. PubMed ID: 7083631
[TBL] [Abstract][Full Text] [Related]
14. The critical concentration of C1-esterase inhibitor (C1-INH) in human serum preventing auto-activation of the first component of complement (C1).
Windfuhr JP; Alsenz J; Loos M
Mol Immunol; 2005 Apr; 42(6):657-63. PubMed ID: 15781109
[TBL] [Abstract][Full Text] [Related]
15. Cytokines associated with amyloid plaques in Alzheimer's disease brain stimulate human glial and neuronal cell cultures to secrete early complement proteins, but not C1-inhibitor.
Veerhuis R; Janssen I; De Groot CJ; Van Muiswinkel FL; Hack CE; Eikelenboom P
Exp Neurol; 1999 Nov; 160(1):289-99. PubMed ID: 10630213
[TBL] [Abstract][Full Text] [Related]
16. Complement levels of C4, C3C, factor B, and C1 inactivator in peripheral and retroplacental blood of parturient women with EPH gestosis.
Zdanowicz A; Jabłońska E; Pietruska Z; Bielecki M
Ann Med Univ Bialyst Pol; 1993; 38(1):60-7. PubMed ID: 7922487
[TBL] [Abstract][Full Text] [Related]
17. [A simplified method for the assessment of C1 esterase inhibitor function].
Deguchi M; Takemura S; Ueda M; Kasamatsu Y; Yanagida K; Fukuda W; Okamoto M; Onodera H; Sugino S; Kondo M
Ryumachi; 1990 Jun; 30(3):166-71. PubMed ID: 2244251
[TBL] [Abstract][Full Text] [Related]
18. Molecular basis of complement resistance of human melanoma cells expressing the C3-cleaving membrane protease p65.
Ollert MW; Kadlec JV; Petrella EC; Bredehorst R; Vogel CW
Cancer Res; 1993 Feb; 53(3):592-9. PubMed ID: 8425193
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effect of K-76 monocarboxylic acid, an anticomplementary agent, on the C3b inactivator system.
Hong K; Kinoshita T; Kitajima H; Inoue K
J Immunol; 1981 Jul; 127(1):104-8. PubMed ID: 7240739
[TBL] [Abstract][Full Text] [Related]
20. Purification of the human complement control protein C3b inactivator.
Crossley LG; Porter RR
Biochem J; 1980 Oct; 191(1):173-82. PubMed ID: 6451220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
